| Literature DB >> 31877950 |
Shaokun Liu1, Xia Zou1, Xiaoling Huang1, Yin Liu1, Qian Lu1, Li Ling1.
Abstract
The quality of family relationships is important for individual and family well-being. Improving family relationships is also an important goal in methadone maintenance treatment (MMT). Little is known about factors associated with the improvement of family relationships among MMT clients. This study aimed to identify factors associated with family relationship improvement in MMT. We retrospectively analyzed existing data from 2006 to 2014 at 15 MMT clinics in Guangdong, China, including 2171 subjects with 4691 follow-ups. Generalized estimating equations were used to investigate the association between living status transitions, behavior changes and family relationship improvement, with covariates controlled for. Family relationship improvement was found in 23.1% of all follow-up intervals. Participants who began living with family, living on a regular wage, and gained employment were more likely to have improved family relationships. The quality of family relationships also improved among participants who ceased contact with drug-addicted fellows, ceased drug use, and those who were sexually active. These results suggest that improvement in living status, positive changes in drug use, and sexual activity are associated with family relationship improvement and corresponding interventions may be developed to facilitate clients' recovery.Entities:
Keywords: behavior changes; family relationship; living status transitions; methadone maintenance treatment
Mesh:
Substances:
Year: 2019 PMID: 31877950 PMCID: PMC6981571 DOI: 10.3390/ijerph17010119
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Characteristics of methadone maintenance treatment participants included in this study (n = 2171).
| Characteristics | |
|---|---|
| Demographic characteristics | |
| Gender | |
| Female | 243 (11.2) |
| Male | 1928 (88.8) |
| Age, mean ± SD | 36.5 ± 6.6 |
| Ethnicity | |
| Han | 2148 (98.9) |
| Minorities | 23 (1.1) |
| Educational level | |
| Primary school and below | 409 (18.8) |
| Middle school and above | 1762 (81.2) |
| Marital status | |
| Unmarried | 935 (43.1) |
| Married | 1045 (48.1) |
| Divorced/widowed/others | 191 (8.8) |
| Drug use history and HIV/HCV infection | |
| Age of initial drug use, median (Q1, Q3) | 23.0 (20.0, 27.0) |
| Years of drug use, median (Q1, Q3) | 13.0 (9.0, 16.0) |
| Intravenous drug use | |
| No | 482 (22.2) |
| Yes | 1689 (77.8) |
| HIV infection at baseline | |
| No | 2058 (94.8) |
| Yes | 113 (5.2) |
| HCV infection at baseline | |
| No | 459 (21.1) |
| Yes | 1712 (78.9) |
SD, standard deviation; Q1, lower quartile; Q3, upper quartile.
Family relationship improvement, living status transitions, behavior changes, and methadone maintenance treatment (MMT) related characteristics during follow-up intervals (n = 4691).
| Characteristics | |
|---|---|
| Family relationship improvement | |
| Improved | 1085 (23.1) |
| Not improved | 3606 (76.9) |
| Living status transitions | |
| Residential status | |
| Unchanged | 4105 (87.5) |
| Living with family | 3707 (79.0) |
| Not living with family | 398 (8.5) |
| Began living with family | 315 (6.7) |
| Ceased living with families | 271 (5.8) |
| Main source of living cost | |
| Unchanged | 3572 (76.1) |
| Living on a regular wage | 609 (12.9) |
| Not living on a regular wage | 2963 (63.2) |
| Began living on a regular wage | 685 (14.6) |
| Lost a regular wage | 434 (9.3) |
| Employment status | |
| Unchanged | 3142 (67.0) |
| Employed | 1601 (34.1) |
| Not employed | 1541 (32.9) |
| Gained employment | 981 (20.9) |
| Lost employment | 568 (12.1) |
| Behavior changes | |
| Contact with drug-addicted fellows | |
| Unchanged | 2908 (62.0) |
| Contacting with drug-addicted fellows | 1155 (24.6) |
| Not contacting with drug-addicted fellows | 1753 (37.4) |
| Began contact | 481 (10.3) |
| Ceased contact | 1302 (27.8) |
| Concurrent drug use | |
| Unchanged | 2659 (56.7) |
| Using drugs | 1262 (26.9) |
| Not using drugs | 1397 (29.8) |
| Began drug use | 341 (7.3) |
| Ceased drug use | 1691 (36.0) |
| Sexual behavior | |
| Unchanged | 3256 (69.4) |
| Having sexual activity | 1977 (42.1) |
| Not having sexual activity | 1279 (27.3) |
| Were sexually active | 690 (14.7) |
| Were sexually inactive | 745 (15.9) |
| MMT-related characteristics during follow-up intervals | |
| Dosage of methadone a | |
| <30 mg | 518 (11.0) |
| 30–60 mg | 2159 (46.0) |
| 60–100 mg | 1693 (36.1) |
| ≥100 mg | 321 (6.8) |
| Attendance rate b | |
| <50% | 263 (5.6) |
| 50%–80% | 952 (20.3) |
| ≥80% | 3476 (74.1) |
| Urine test participation rate c | |
| <50% | 325 (6.9) |
| 50%–80% | 982 (20.9) |
| ≥80% | 3384 (72.1) |
| Urine positive rate d | |
| <20% | 2434 (51.9) |
| 20%–60% | 1396 (29.8) |
| ≥60% | 861 (18.4) |
| Length of follow-up intervals (month), median (Q1, Q3) | 6.7 (6.0, 12.2) |
a, defined as median daily dosage of an MMT participant during a follow-up interval; b, defined as the ratio of the number of days a participant actually received a methadone dose to the total days of a follow-up interval; c, calculated by dividing the times of tests a participant actually attended by the total times of tests one should attend during a follow-up interval; d, calculated by dividing the times of positive results by the total times of tests one actually attended during a follow-up interval.
GEE analysis exploring the association between living status transitions, behavior changes and family relationship improvement (n = 2171).
| Variables | Univariable | Multivariable | ||
|---|---|---|---|---|
| OR (95% CI) | aOR (95% CI) | |||
| Living status transitions | ||||
| Residential status | ||||
| Ceased living with family | 0.98 (0.72, 1.32) | 0.881 | 1.00 (0.73, 1.36) | 0.999 |
| Began living with family | 1.50 (1.17, 1.93) | 0.001 | 1.51 (1.16, 1.96) | 0.002 |
| Unchanged | 1.00 | 1.00 | ||
| Main source of living cost | ||||
| Lost a regular wage | 0.66 (0.50, 0.87) | 0.003 | 0.83 (0.62, 1.09) | 0.176 |
| Began living on a regular wage | 1.70 (1.42, 2.04) | <0.001 | 1.36 (1.12, 1.65) | 0.002 |
| Unchanged | 1.00 | 1.00 | ||
| Employment status | ||||
| Lost employment | 0.68 (0.53, 0.87) | 0.002 | 0.73 (0.56, 0.93) | 0.013 |
| Gained employment | 1.91 (1.62, 2.23) | <0.001 | 1.56 (1.32, 1.85) | <0.001 |
| Unchanged | 1.00 | 1.00 | ||
| Behavioral changes | ||||
| Contact with drug-addicted fellows | ||||
| Ceased contact | 2.19 (1.88, 2.55) | <0.001 | 1.84 (1.57, 2.17) | <0.001 |
| Began contact | 0.94 (0.73, 1.21) | 0.619 | 0.96 (0.73, 1.24) | 0.736 |
| Unchanged | 1.00 | 1.00 | ||
| Concurrent drug use | ||||
| Ceased drug use | 1.59 (1.37, 1.84) | <0.001 | 1.22 (1.03, 1.43) | 0.019 |
| Began drug use | 0.60 (0.43, 0.84) | 0.003 | 0.65 (0.46, 0.91) | 0.013 |
| Unchanged | 1.00 | 1.00 | ||
| Sexual behavior | ||||
| Were sexually inactive | 1.01 (0.83, 1.23) | 0.930 | 0.94 (0.77, 1.15) | 0.560 |
| Were sexually active | 1.79 (1.49, 2.15) | <0.001 | 1.67 (1.38, 2.02) | <0.001 |
| Unchanged | 1.00 | 1.00 | ||
| Demographic characteristics | ||||
| Gender | ||||
| Male | 1.17 (0.94, 1.45) | 0.170 | 1.16 (0.93, 1.45) | 0.194 |
| Female | 1.00 | 1.00 | ||
| Age | 0.99 (0.98, 1.00) | 0.151 | 1.00 (0.99, 1.01) | 0.800 |
| Ethnicity | ||||
| Minorities | 0.83 (0.45, 1.53) | 0.548 | ||
| Han | 1.00 | |||
| Educational level | ||||
| Middle school and above | 0.97 (0.83, 1.13) | 0.674 | ||
| Primary school and below | 1.00 | |||
| Marital status | ||||
| Married | 1.01 (0.88, 1.15) | 0.934 | ||
| Divorced/widowed/others | 1.04 (0.83, 1.31) | 0.720 | ||
| Unmarried | 1.00 | |||
| Drug use history and HIV/HCV infection | ||||
| Age of initial drug use | 1.00 (0.99, 1.01) | 0.437 | ||
| Years of drug use | 1.01 (0.99, 1.02) | 0.338 | ||
| Injecting drug use | ||||
| Yes | 1.24 (1.06, 1.45) | 0.006 | 1.10 (0.92, 1.31) | 0.282 |
| No | 1.00 | 1.00 | ||
| HIV infection at baseline | ||||
| Yes | 1.21 (0.93, 1.57) | 0.162 | 1.21 (0.92, 1.60) | 0.175 |
| No | 1.00 | 1.00 | ||
| HCV infection at baseline | ||||
| Yes | 1.29 (1.11, 1.51) | 0.001 | 1.19 (1.00, 1.42) | 0.046 |
| No | 1.00 | 1.00 | ||
| MMT-related characteristics during follow-up intervals | ||||
| Average dosage of methadone | ||||
| <30 mg | 1.20 (0.87, 1.66) | 0.276 | 1.16 (0.83, 1.62) | 0.389 |
| 30–60 mg | 1.22 (0.92, 1.61) | 0.166 | 1.16 (0.87, 1.55) | 0.324 |
| 60–100 mg | 1.28 (0.97, 1.71) | 0.086 | 1.24 (0.93, 1.66) | 0.149 |
| ≥100 mg | 1.00 | 1.00 | ||
| Attendance rate | ||||
| ≥80% | 1.09 (0.83, 1.44) | 0.523 | 1.21 (0.91, 1.62) | 0.189 |
| 50–80% | 1.26 (0.92, 1.71) | 0.149 | 1.23 (0.90, 1.68) | 0.195 |
| <50% | 1.00 | 1.00 | ||
| Urine test participation rate | ||||
| ≥80% | 0.65 (0.51, 0.83) | <0.001 | 0.78 (0.61, 1.01) | 0.058 |
| 50–80% | 1.04 (0.79, 1.36) | 0.779 | 1.16 (0.88, 1.53) | 0.306 |
| <50% | 1.00 | 1.00 | ||
| Urine positive rate | ||||
| ≥60% | 0.90 (0.74, 1.08) | 0.252 | 0.95 (0.77, 1.17) | 0.644 |
| 20–60% | 1.20 (1.03, 1.40) | 0.021 | 1.15 (0.97, 1.35) | 0.099 |
| <20% | 1.00 | 1.00 | ||
| Length of follow-up intervals (month) | 0.99 (0.97, 1.00) | 0.132 | 1.00 (0.99, 1.02) | 0.828 |
OR, odds ratio; CI, confidence interval. aOR, adjusted OR.